Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
01:31:22 15/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 53.10 CHF | +0.19% |
|
+2.51% | -2.93% |
| 06/08 | Swiss Market Index Extends Rally; Sandoz Shares Gain | MT |
| 05/08 | Basilea Pharmaceutica Bags Additional $5 Million Funding for Antibiotic Development | MT |
| Market Cap | 658M 811M 700M 599M 1.13B 77.55B 1.14B 7.71B 3.02B 38.83B 3.04B 2.98B 129B | P/E 2026 * |
13x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 509M 628M 542M 463M 871M 60.02B 885M 5.97B 2.33B 30.06B 2.36B 2.31B 99.88B | EV / Sales 2026 * |
1.95x | EV / Sales 2027 * | 1.65x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | +0.19% | ||
| 1 week | +2.51% | ||
| Current month | +2.31% | ||
| 1 month | +1.34% | ||
| 3 months | -3.63% | ||
| 6 months | -6.84% | ||
| Current year | -2.93% |
| 1 week | 51.8 |  | 53.6 |
| 1 month | 50.4 | | 53.6 |
| Current year | 47.8 | | 59.2 |
| 1 year | 44.7 | | 59.2 |
| 3 years | 32 | | 59.7 |
| 5 years | 29.55 | | 59.7 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/5/26 | Sell | -400 | 0.0030% | |||
| 25/2/26 | Fiscal year | 1,500 | 0.0113% | |||
| 20/2/26 | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.19% | +2.51% | +2.12% | +12.14% | 811M | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| Average | -0.58% | +0.75% | +69.58% | +99.54% | 26.4B | |
| Weighted average by Cap. | -0.91% | +0.60% | +95.52% | +132.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 261M 321M 277M 237M 446M 30.71B 453M 3.05B 1.19B 15.38B 1.21B 1.18B 51.1B | 271M 333M 288M 246M 463M 31.87B 470M 3.17B 1.24B 15.96B 1.25B 1.22B 53.04B |
| Net income | 53.56M 65.99M 56.99M 48.71M 91.57M 6.31B 93.08M 628M 245M 3.16B 248M 242M 10.5B | 44.43M 54.74M 47.28M 40.41M 75.97M 5.23B 77.22M 521M 204M 2.62B 206M 201M 8.71B |
| Net Debt | -149M -183M -158M -135M -254M -17.53B -259M -1.74B -682M -8.78B -688M -673M -29.17B | -211M -260M -225M -192M -361M -24.89B -367M -2.47B -968M -12.46B -977M -956M -41.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | CHF 53.10 | +0.19% | 29,468 |
| 13/08/26 | CHF 53.00 | +0.76% | 18,048 |
| 12/08/26 | CHF 52.60 | +1.15% | 44,686 |
| 11/08/26 | CHF 52.00 | -0.19% | 31,420 |
| 10/08/26 | CHF 52.10 | +0.58% | 11,367 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
